Article 11 Mar 2024 Non-Binding Guidance: Preview Of The Second Annual Ropes & Gray Rare Disease Forum (Podcast) United States Healthcare
Article 23 Feb 2024 Inching Toward Harmonization: FDA Finalizes Rule On IRB Waiver Of Informed Consent For Minimal Risk Studies United States Healthcare
Article 30 Jan 2024 U.S. Life Sciences Regulatory And Compliance Outlook 2024 (Part II): Product Development And Pricing (Podcast) United States Healthcare
Article 21 Nov 2023 Non-Binding Guidance: FDA's Draft Guidance On Communication Of Scientific Information On Unapproved Uses Of Medical Products (Podcast) United States Healthcare